An alternative explanation could be that GIPR targeting produces a relatively weak anorectic signal and thus appetite reduction is only possible in models where appetite regulation is disrupted, for example, HFD‐induced obesity. Here, GIPR is linked to obesity due to melanocortin 4 receptor deficiency.